DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
Other share classesDBVTF
Insider trades, last 90 days
0 buys · 1 sell
- Sold $1.25K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
78
- +7 vs. Q1 2026
- Total value $345.69M
Superinvestors holding DBVT
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by DBVT insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 20264:15 PM ET | Jul 29, 2026 | Mohideen PharisChief Medical Officer | SSaleOrdinary Shares | −464 | $2.70 | −$1.25K | 144.53K | −0.3% | SEC |
| Feb 2, 2026 | Jan 29, 2026 | Mohideen PharisChief Medical Officer | SSaleOrdinary Shares | −534 | $4.86 | −$2.6K | 145K | −0.4% | SEC |
| Dec 19, 20254:04 PM ET | Dec 17 – Dec 18, 2025 | CAISSE DES DEPOTS ET CONSIGNATIONS and 4 othersOther: Member of 10% owner group | SSaleOrdinary Shares | −3.37M | $4.5959 | −$15.48M | 7.3M | −31.6% | SEC |
| Nov 25, 2025 | Nov 20 – Nov 21, 2025 | Mohideen PharisChief Medical Officer | SSaleOrdinary Shares | −8.12K | $2.858 | −$23.21K | 101.53K | −7.4% | SEC |
| Jul 31, 2025 | Jul 29, 2025 | Mohideen PharisChief Medical Officer | SSaleOrdinary Shares | −464 | $2.22 | −$1.03K | 109.65K | −0.4% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in DBVT at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 3,666,284 | $60.13M | 3.67% | −1,547,077−29.7% | Reduced |
| Siren, L.L.C. | 1,857,362 | $30.46M | 0.62% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,844,758 | $30.25M | 2.76% | −822,811−30.8% | Reduced |
| PERCEPTIVE ADVISORS LLC | 1,653,350 | $27.11M | 0.42% | +688,959+71.4% | Added |
| BAKER BROS. ADVISORS LP | 1,461,425 | $23.97M | 0.12% | 00.0% | Unchanged |